Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$164
Market cap
$394.79B
P/E Ratio
10.77
Dividend/share
$4.86
EPS
$15.23
Enterprise value
$411.4B
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones
Highlights
Johnson & Johnson's net income has surged by 191% YoY
JNJ's price to earnings (P/E) is 52% lower than its 5-year quarterly average of 22.3
Johnson & Johnson's debt has increased by 23% from the previous quarter but it has decreased by 9% YoY
JNJ's equity is down by 4.8% year-on-year but it is up by 2.2% since the previous quarter
The quick ratio has decreased by 8% QoQ and by 8% YoY
Key stats
What are the main financial stats of JNJ
Market
Valuations
Earnings
Shares outstanding
2.41B
Market cap
$394.79B
Enterprise value
$411.4B
Price to earnings (P/E)
10.77
Price to book (P/B)
5.52
Price to sales (P/S)
5.01
EV/EBIT
10.04
EV/EBITDA
8.53
EV/Sales
5.23
Revenue
$78.71B
EBIT
$40.96B
EBITDA
$48.23B
Free cash flow
$20.3B
Per share
Balance sheet
Liquidity
EPS
$15.23
Free cash flow per share
$8.44
Book value per share
$29.72
Revenue per share
$32.7
TBVPS
$40.35
Total assets
$181.09B
Total liabilities
$109.55B
Debt
$41.49B
Equity
$71.54B
Working capital
$3.88B
Debt to equity
0.58
Current ratio
1.07
Quick ratio
0.77
Net debt/EBITDA
0.34
Margins
Efficiency
Dividend
EBITDA margin
61.3%
Gross margin
70.4%
Net margin
48.3%
Operating margin
25.7%
Return on assets
22.1%
Return on equity
54%
Return on invested capital
68.5%
Return on capital employed
32.2%
Return on sales
52%
Dividend yield
2.96%
DPS
$4.86
Payout ratio
31.9%
JNJ stock price
How has the Johnson & Johnson stock price performed over time
Intraday
1.49%
1 week
2.7%
1 month
-0.92%
1 year
4.56%
YTD
4.63%
QTD
1.2%
Financial performance
How have Johnson & Johnson's revenue and profit performed over time
Revenue
$78.71B
Gross profit
$55.39B
Operating income
$20.24B
Net income
$38.02B
Gross margin
70.4%
Net margin
48.3%
Johnson & Johnson's net income has surged by 191% YoY
Johnson & Johnson's net margin has soared by 178% YoY but it has decreased by 2.4% from the previous quarter
JNJ's revenue is up by 5% year-on-year
The gross profit is up by 5% YoY
Growth
What is Johnson & Johnson's growth rate over time
Valuation
What is Johnson & Johnson stock price valuation
P/E
10.77
P/B
5.52
P/S
5.01
EV/EBIT
10.04
EV/EBITDA
8.53
EV/Sales
5.23
JNJ's price to earnings (P/E) is 52% lower than its 5-year quarterly average of 22.3
JNJ's price to book (P/B) is 8% less than its 5-year quarterly average of 5.9
JNJ's equity is down by 4.8% year-on-year but it is up by 2.2% since the previous quarter
JNJ's revenue is up by 5% year-on-year
The price to sales (P/S) is 3.1% less than the 5-year quarterly average of 5.1 but 2.9% more than the last 4 quarters average of 4.8
Efficiency
How efficient is Johnson & Johnson business performance
The ROS has soared by 159% YoY
Johnson & Johnson's return on invested capital has increased by 3.6% QoQ
Dividends
What is JNJ's dividend history
DPS
$4.86
Dividend yield
2.96%
Payout ratio
31.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Johnson & Johnson financials performed over time
JNJ's total assets is 65% greater than its total liabilities
JNJ's current ratio is down by 9% since the previous quarter and by 4.5% year-on-year
The quick ratio has decreased by 8% QoQ and by 8% YoY
Johnson & Johnson's debt is 42% less than its equity
Johnson & Johnson's debt has increased by 23% from the previous quarter but it has decreased by 9% YoY
The company's debt to equity rose by 21% QoQ but it fell by 4.9% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.